PHADEBACT CSF POSITIVE CONTROLS— 510(k) K840048

Name: FDA 510(k) clearance K840048
Creator: U.S. Food and Drug Administration
Published: 1984-03-02

Substantially Equivalent

Pharmacia, Inc.

FDA 510(k) clearance K840048 for PHADEBACT CSF POSITIVE CONTROLS, Substantially Equivalent on 1984-03-02. Applicant: Pharmacia, Inc.. Device class: 1.

Clearance details

Applicant: Pharmacia, Inc.
Product code: Code GTY
Device class: Class 1
Regulation: 21 CFR 866.3740
Advisory panel: Microbiology
Date received: 1984-01-06
Decision date: 1984-03-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GTY

view all

K260342 — AllTest Strep A Rapid Test2026-04-30
K251697 — Flowflex® Plus Strep A Rapid Test Cassette; Flowflex® Plus Strep A Rapid Test Strip2025-11-26
K212623 — Healgen Strep A Rapid Test Strip (Throat Swab)2022-03-16
K171976 — Sofia Strep A+ FIA, Sofia 2 Analyzer2017-12-21
K141775 — SOFIA (R) STREP A+ FIA2014-12-16

More clearances from Pharmacia, Inc.

view all

K974350 — ALLERGAN IMMUNO CAP M4, M8, K701998-02-09
K972364 — UNICAP PHADIATOP1997-09-04
K972068 — UNICAP SPECIFIC IGE FEIA ASSAY, LATEX ALLERGEN IMMUNOCAP K821997-07-03
K970420 — MASTERCAP AM 5.0/MASTERCAP RM 5.01997-06-30
K964152 — UNICAP TOTAL IGE ASSAY/PHARMACIA TOTAL IGE CONTROLS LMH1997-04-23

Adverse events under product code GTY

product code GTY

Death: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.